| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |